1. Effect of NYD-SP27 down-regulation on ATP-induced Ca2+-dependent pancreatic duct anion secretion in cystic fibrosis cells
- Author
-
Zhu, Jin Xia, Yang, Ning, Zhu, Hu, Chung, Yiu Wa, and Chan, Hsiao Chang
- Subjects
- *
ADENOSINE triphosphate , *PANCREATIC duct , *CYSTIC fibrosis , *ANIONS - Abstract
Abstract: Our previous study demonstrated that NYD-SP27 is a novel inhibitory PLC isoform expressed endogenously in human pancreas and upregulated in CFPAC-1 cells. The present study investigated the effect of NYD-SP27 down-regulation on the ATP-stimulated and Ca2+-dpendent pancreatic anion secretion by CFPAC-1 cell line using short-circuit current (I SC) recording. NYD-SP27 antisense-transfected CFPAC-1 (AT-CF) cells exhibited a significantly higher basal transmembrane potential difference and current than those of empty vector-transfected CFPAC-1 (VT-CF) cells. Cl− channel blocker, DPC or Glibenclamide (1mM), and inhibitor of Na+-K+-Cl− cotransporter, bumetanide (100μM) significantly inhibited the basal current in AT-CF cells. The inhibitor of adenylate cyclase, MDL12330A (20μM), and Ca2+-dependent Cl− channel (CaCC) blocker, DIDS (100μM) also significantly reduced the basal current in AT-CF. Apical application of ATP (10μM) stimulated a fast transient I SC increase in VT-CF cells, but a more sustained rise with slower decline in AT-CF cells. Pretreatment with BAPTA-AM (50μM) reduced the ATP-induced I SC response in AT-CF cells by 77.9%. PMA (1μM), a PKC activator, inhibited the ATP-stimulated current increase (the transient peak) in VT-CF cells, but had no effect on the AT-CF cells. However, PKC inhibitor, staurosporine (40μM) could inhibit the ATP-induced I SC response in AT-CF cells. The present results confirm the previously proposed inhibitory role of NYD-SP27 in the PLC pathway and demonstrate that the suppression of its expression could result in an enhancement of ATP-stimulated Ca2+ dependent pancreatic anion secretion. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF